TTRX
Turn Therapeutics Inc.Company with tickers: TTRX
CIK
2023016
CUSIP
90021W105
Shares Outstanding
29,788,040
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $1,246,143 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Research & Development | $109,434 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Operating Income | $-1,246,143 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Net Income | $-970,972 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| EPS (Basic) | $-0.03 | USD/shares | 2026-03-31 | 10-Q | 2026-05-11 |
| EPS (Diluted) | $-0.03 | USD/shares | 2026-03-31 | 10-Q | 2026-05-11 |